分化型甲状腺癌全切术后甲状旁腺功能减退对骨小梁评分与骨密度的影响
本研究比较了分化型甲状腺癌全切术后合并甲状旁腺功能减退(HypoPT)与甲状旁腺功能正常女性患者的骨小梁评分、骨密度及骨转换标志物。中位随访10年发现,绝经后HypoPT患者骨密度和骨小梁评分更高,骨转换标志物更低,提示HypoPT可能对长期TSH抑制治疗下的骨骼具有保护作用。
要点
- 绝经后HypoPT患者末次随访时腰椎、髋部及桡骨远端骨密度高于甲状旁腺功能正常者(P=.001)。
- 绝经后HypoPT患者骨小梁评分更高(1.31±0.09 vs 1.24±0.12,P=.0184)。
- 绝经前患者两组骨密度无显著差异,HypoPT对骨骼的影响主要见于绝经后人群。
核心结论
- 全甲状腺切除术后发生甲状旁腺功能减退的绝经后分化型甲状腺癌患者,其骨小梁评分和骨密度较甲状旁腺功能正常者更高,提示甲状旁腺功能减退可能减轻长期TSH抑制治疗对骨骼的负面影响。
研究设计与样本
- 研究纳入因分化型甲状腺癌行全甲状腺切除的女性,按年龄和体重指数匹配,比较术后甲状旁腺功能减退组(n=25,其中绝经前8例、绝经后17例)与甲状旁腺功能正常组(n=98,其中绝经前14例、绝经后84例)。
- 基线(术后1-3个月)及末次随访时采用双能X线吸收法测定骨密度,Med-Imaps软件分析骨小梁评分,并检测骨转换标志物。
- 随访期间患者接受促甲状腺激素抑制治疗,两组随访时间相似(中位10年)。
主要发现
- 基线时两组骨密度和骨小梁评分相似,无论绝经状态如何。
- 末次随访时,绝经后甲状旁腺功能减退组腰椎、髋部及桡骨远端骨密度均高于甲状旁腺功能正常组(P=.001)。
- 绝经后甲状旁腺功能减退组骨小梁评分为1.31±0.09,高于甲状旁腺功能正常组的1.24±0.12(P=.0184)。
- 绝经前两组患者末次随访时骨密度值相似。
- 绝经后甲状旁腺功能减退组骨转换标志物(骨钙素、骨特异性碱性磷酸酶、β-胶原特殊序列)水平更低,反映骨转换降低。
临床怎么用
- 对于全甲状腺切除术后合并甲状旁腺功能减退的绝经后女性,在长期TSH抑制治疗中可关注其骨密度和骨小梁评分,该人群骨骼状态可能优于甲状旁腺功能正常者。
- 绝经前甲状旁腺功能减退患者骨骼参数与甲状旁腺功能正常者相似,随访策略可参照一般人群。
局限性
- 研究为单中心观察性设计,样本量较小(甲状旁腺功能减退组共25例)。
- 未报告甲状旁腺功能减退的病程、严重程度及具体治疗细节。
- 骨转换标志物降低与骨保护作用的因果关系尚不能确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although bone mineral density is reported to be increased in patients with postsurgical hypoparathyroidism (postsurgical HypoPT), the effect of HypoPT on trabecular bone score remains unknown. This study evaluated the long-term effects of HypoPT secondary to total thyroidectomy for differentiated thyroid cancer on trabecular bone score, bone mineral density, and bone turnover markers with a similar group of patients without HypoPT. METHODS: Women with resected differentiated thyroid cancer and either postsurgical HypoPT (n = 25; 8 premenopausal and 17 postmenopausal) or euparathyroid function (n = 98; 14 premenopausal and 84 postmenopausal) were matched for age and body mass index. Patients received thyroid-stimulating hormone suppression during follow-up. The bone mineral density and trabecular bone score were analyzed using dual x-ray densitometry and Med-Imaps software at baseline (1-3 months postsurgery) and at the final study visit. RESULTS: Follow-up duration was similar in studied groups (median 10 years). Baseline bone mineral density and trabecular bone score were similar between HypoPT and non-HypoPT patients, regardless of menopausal status. At study end, postmenopausal HypoPT patients had greater bone mineral density versus the non-HypoPT patients at the lumbar spine, hip, and distal radius (P = .001), and a greater trabecular bone score (1.31 ± 0.09 vs 1.24 ± 0.12, P = .0184). Premenopausal patients with and without HypoPT had similar bone mineral density values at the final evaluation. The bone turnover markers (osteocalcin, bone-specific alkaline phosphatase, and β-crosslaps) were less in postmenopausal HypoPT patients, reflecting decreased bone turnover. CONCLUSION: Postmenopausal patients who underwent a total thyroidectomy for differentiated thyroid cancer with postsurgical HypoPT have greater trabecular bone score and bone mineral density compared with euparathyroid patients, suggesting that HypoPT protects against the negative effects of long-term thyroid-stimulating hormone suppression treatment on bone.
引用
- Iglesias SG, Dominguez MLM, Herrero EF, et al. Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma. Surgery. 2018. PMID: 30554726. doi:10.1016/j.surg.2018.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。